Morgan Stanley Maintains Overweight on Tenet Healthcare, Raises Price Target to $274

Morgan Stanley analyst Craig Hettenbach maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $254 to $274.